Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.07, read 2026-11-05
Ethical passes the values gate
Price67.33 USD
Fair value81.25
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-11Read Markup63.24+6.5% to today ✓Markdown gives way to Markup after a 9% slide in 4 weeks
2026-09-15Read Markdown69.53-3.2% to today ✓Markup gives way to Markdown after a 47% rise in 11 weeks
2026-07-02Read Markup47.38+42.1% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
TriNet Group, Inc. holds its Markup at $67.33. Consolidating, no directional conviction, held for 24 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 24 days
Price at the screen
$67.33
Valuation
18.00 trailing · 13.33 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.97
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
24.81%
Below 33%
Interest-bearing debt is just 24.8% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
8.09%
Below 49%
Money owed to the company is 8.1% of assets, under the 49% limit.
Pass
Revenue purity
1.44%
Below 5%
Only 1.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
TriNet Group, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 25%, inside the ~33% line, and interest is about 1% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when TNET's ethical verdict changes
Today TNET passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 17% discount to our $81.25 fair value.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 17.1% discount to the base estimate.
Where our models see it going: fair-value estimate $81.25, with a range of $75.14 to $125.23, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Small firm payroll handler faces flat prospects
Imagine a workshop owner in Ohio trying to run payroll and health cover across three states without a dedicated HR team. TriNet steps in with the back office, yet revenue is already falling 5% and margins sit at just 3%. Even with our fair value only a touch above the current price, the opportunity rating stays at none.
The 12.3 times forward earnings and sky high 218% ROE look attractive on paper, but analysts place median targets at 50 dollars and see no clear catalyst. Ethical checks pass without issue, yet the business shows no durable edge in a crowded staffing market.
Staffing volumes swing hard with the cycle, so low margins today could mask peak earnings rather than a bargain. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
TNET trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Markup$66.77-5.2%Entry 17
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 5.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 43% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 40%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (5 analysts) rates it hold, with a mean price target of $51.
2026-10-29Markup$70.41-0.9%Entry 16
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 43% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 40%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (5 analysts) rates it hold, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markup$71.03+0.0%Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 43% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 40%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (5 analysts) rates it hold, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markup$71.03+0.0%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 43% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 40%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (5 analysts) rates it hold, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markup$71.03+0.0%Entry 13
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 43% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 40%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (5 analysts) rates it hold, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markup$71.03+0.0%Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 40%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (5 analysts) rates it hold, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markup$71.03+0.0%Entry 11
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 40%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (5 analysts) rates it hold, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markup$71.03+0.0%Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 40%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (5 analysts) rates it hold, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markup$71.03+0.9%Entry 9
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 40%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (5 analysts) rates it hold, with a mean price target of $51. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markup$70.39+11.3%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 40%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (5 analysts) rates it hold, with a mean price target of $51.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.